Global Active Implantable Medical Devices Market, By Product (Implantable Cardioverter Defibrillators, Ventricular Assist Devices, Implantable Cardiac Pacemakers, Dental Implants, Implantable Hearing Devices, Ventricular Assist Devices, Neurostimulators), End User (Hospitals, Ambulatory Centers, Cardiac Centers, Dental Clinics, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2029
Market Analysis and Insights : Global Active Implantable Medical Devices Market
The implantable medical devices market is expected to witness market growth at a rate of 8.00% in the forecast period of 2022 to 2029. Data Bridge Market Research report on implantable medical devices market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The rise in the healthcare sector globally is escalating the growth of implantable medical devices market.
Active implantable medical devices refer to the type of devices that are intended into a patient’s body totally or partially. These devices are intended for diagnostic or therapeutic purposes in the human body. The devices enter the human body either through a natural orifice or by surgical means.
The increase in burden of cardiovascular diseases across the globe acts as one of the major factors driving the growth of implantable medical devices market. The investments and funds to develop technologically advanced products, and favorable reimbursement scenario for ENT procedures in developed countries accelerate the market growth. The rise in the incidences of neurological disorders and expansion of applications of neurostimulators further influence the market. Additionally, rise in prevalence of geriatric population, surge in healthcare expenditure, advancements in healthcare infrastructure and high disposable income positively affect the implantable medical devices market. Furthermore, development of subcutaneous implantable cardioverter defibrillators (S-ICDs) extend profitable opportunity to the market players in the forecast period of 2022 to 2029.
On the other hand, high cost of implants and an unfavorable reimbursement scenario and issues related to the use of implantable medical devices are obstruct the market growth. The increase in pricing pressure and dearth of skilled professionals are projected to challenge the implantable medical devices market in the forecast period of 2022-2029.
This implantable medical devices market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on implantable medical devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Active Implantable Medical Devices Market Scope and Market Size
The implantable medical devices market is segmented on the basis of product and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of product, the implantable medical devices market is segmented into implantable cardioverter defibrillators, ventricular assist devices, implantable cardiac pacemakers, dental implants, implantable hearing devices, ventricular assist devices and neurostimulators. Implantable cardioverter defibrillators is further sub-segmented into transvenous, and subcutaneous. Transvenous defibrillators are again sub-segmented into biventricular implantable cardioverter defibrillators (ICDs)/cardiac resynchronization therapy defibrillators (CRT-Ds), single-chamber implantable cardioverter defibrillators, and dual-chamber implantable cardioverter defibrillators. Implantable hearing devices are further sub-segmented into active hearing implants, and passive hearing implants. Neurostimulators are further sub-segmented into deep brain stimulators, spinal cord stimulators, sacral nerve stimulators, vagus nerve stimulators and gastric electrical stimulators.
- On the basis of end user, the implantable medical devices market is segmented into hospitals, ambulatory centers, cardiac centers, dental clinics and others.
Active Implantable Medical Devices Market Country Level Analysis
The implantable medical devices market is analyzed and market size insights and trends are provided by country, product and end user as referenced above.
The countries covered in the implantable medical devices market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the implantable medical devices market because of the increase in prevalence of cardiovascular and neurological diseases within the region. Asia-Pacific is expected to witness significant growth during the forecast period of 2022 to 2029 due to the growth in geriatric population in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands impact of sales channels are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The implantable medical devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for implantable medical devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the implantable medical devices market. The data is available for historic period 2010-2020.
Competitive Landscape and Active Implantable Medical Devices Market Share Analysis
The implantable medical devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to implantable medical devices market.
Some of the major players operating in the implantable medical devices market report are Boston Scientific Corporation, Cochlear Ltd., Zimmer Biomet, Smith & Nephew, Johnson & Johnson Services, Inc., BIOTRONIK SE & Co. KG, LivaNova PLC, Abbott, Straumann AG, Medtronic, Integra Lifesciences Holdings Corporation, Stryker, William Demant Holding A/S, Nurotron Biotechnology Co. Ltd., Sonova Holding AG, C.R. Bard Inc., 3M, Dentsply Sirona, Allergan Inc., NuVasive, Inc., Cardinal Health, Inc., Microport Scientific Corporation, CONMED Corporation, Globus Medical, Inc., and MED-EL, among others.
SKU-